TR201900778T4 - İmmünojenik bileşim. - Google Patents
İmmünojenik bileşim. Download PDFInfo
- Publication number
- TR201900778T4 TR201900778T4 TR2019/00778T TR201900778T TR201900778T4 TR 201900778 T4 TR201900778 T4 TR 201900778T4 TR 2019/00778 T TR2019/00778 T TR 2019/00778T TR 201900778 T TR201900778 T TR 201900778T TR 201900778 T4 TR201900778 T4 TR 201900778T4
- Authority
- TR
- Turkey
- Prior art keywords
- protein
- saccharide
- saccharides
- meningitidis
- polysaccharides
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 4
- 150000004676 glycans Chemical class 0.000 abstract 4
- 229920001282 polysaccharide Polymers 0.000 abstract 4
- 239000005017 polysaccharide Substances 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 102000014914 Carrier Proteins Human genes 0.000 abstract 2
- 108010078791 Carrier Proteins Proteins 0.000 abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 2
- 230000021615 conjugation Effects 0.000 abstract 2
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN281MU2012 | 2012-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201900778T4 true TR201900778T4 (tr) | 2019-02-21 |
Family
ID=54259032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/00778T TR201900778T4 (tr) | 2012-01-30 | 2013-01-29 | İmmünojenik bileşim. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9198977B2 (ru) |
| EP (1) | EP2809349B1 (ru) |
| JP (1) | JP6042455B2 (ru) |
| KR (1) | KR101897317B1 (ru) |
| CN (1) | CN104302315B (ru) |
| BR (1) | BR112014018815B1 (ru) |
| CA (1) | CA2863178C (ru) |
| DK (1) | DK2809349T3 (ru) |
| ES (1) | ES2707294T3 (ru) |
| HU (1) | HUE040914T4 (ru) |
| MX (1) | MX354103B (ru) |
| PT (1) | PT2809349T (ru) |
| RU (1) | RU2634405C2 (ru) |
| SG (1) | SG11201404447WA (ru) |
| SI (1) | SI2809349T1 (ru) |
| TR (1) | TR201900778T4 (ru) |
| WO (1) | WO2013114268A1 (ru) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8329184B2 (en) | 2005-06-27 | 2012-12-11 | Glaxosmithkline Biologicals S.A. | Process for manufacturing vaccines |
| AU2013349261B2 (en) * | 2012-11-21 | 2017-09-07 | Serum Institute Of India Private Limited | Production of high yields of bacterial polysaccharides |
| CN112999342A (zh) * | 2013-08-24 | 2021-06-22 | 巴拉特生物技术国际有限公司 | 细菌疫苗及其制备方法 |
| EP2921856B1 (en) | 2014-03-18 | 2016-09-14 | Serum Institute Of India Private Limited | A quantitative assay for 4-pyrrolidinopyridine (4-ppy) in polysaccharide-protein conjugate vaccines |
| US10729780B2 (en) * | 2015-06-08 | 2020-08-04 | Serum Institute Of India Private Ltd. | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof |
| WO2017006349A1 (en) * | 2015-07-04 | 2017-01-12 | Bharat Biotech International Limited | Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides |
| BR112018068523A2 (pt) * | 2016-03-15 | 2019-01-22 | Msd Wellcome Trust Hilleman Laboratories Pvt Ltd | novos conjugados de polissacarídeo-proteína e processo para obter os mesmos |
| CN106110316A (zh) * | 2016-06-27 | 2016-11-16 | 北京智飞绿竹生物制药有限公司 | 一种肺炎球菌结合物组合疫苗的制备方法 |
| MX2019002489A (es) | 2016-09-02 | 2019-10-21 | Sanofi Pasteur Inc | Vacuna contra neisseria meningitidis. |
| CN106397537B (zh) * | 2016-10-13 | 2020-01-07 | 李红臣 | 一种高效快速的多糖蛋白结合疫苗纯化分析方法 |
| WO2018203268A1 (en) | 2017-05-05 | 2018-11-08 | Serum Institute Of India Private Limited | Method for removal of impurities from bacterial capsular polysaccharide based preparations |
| CN110809477A (zh) * | 2017-06-27 | 2020-02-18 | 默沙东和惠康基金会合资的希勒曼实验室私人有限公司 | 新型多价多糖-蛋白轭合物疫苗组合物及其制剂 |
| US20200353064A1 (en) * | 2018-01-29 | 2020-11-12 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Novel meningococcal vaccine composition and process thereof |
| WO2019198096A1 (en) * | 2018-04-11 | 2019-10-17 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Tetravalent meningococcal vaccine composition and process to prepare thereof |
| JOP20200214A1 (ar) | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| JP4870895B2 (ja) * | 2000-06-29 | 2012-02-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0130215D0 (en) * | 2001-12-18 | 2002-02-06 | Glaxosmithkline Biolog Sa | Vaccine |
| BRPI0415025A (pt) * | 2003-10-02 | 2006-12-12 | Chiron Srl | vacinas lìquidas para sorogrupos meningocócicos múltiplos |
| GB0513069D0 (en) * | 2005-06-27 | 2005-08-03 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US8329184B2 (en) * | 2005-06-27 | 2012-12-11 | Glaxosmithkline Biologicals S.A. | Process for manufacturing vaccines |
| CA2621023C (en) * | 2005-09-01 | 2019-07-02 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | Multiple vaccination including serogroup c meningococcus |
| PT1962899E (pt) * | 2005-12-22 | 2011-10-19 | Glaxosmithkline Biolog Sa | Vacina conjugada polissacarídica pneumocócica |
| GB0703369D0 (en) * | 2007-02-21 | 2007-03-28 | Health Prot Agency | Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines |
| MX2012006961A (es) * | 2009-12-17 | 2012-10-03 | Fina Biosolutions Llc | Reactivos quimicos para la activacion de polisacaridos en la preparacion de vacunas conjugadas. |
| ES2820898T3 (es) * | 2012-05-22 | 2021-04-22 | Glaxosmithkline Biologicals Sa | Conjugado del serogrupo X de meningococos |
-
2013
- 2013-01-29 SI SI201331329T patent/SI2809349T1/sl unknown
- 2013-01-29 KR KR1020147024348A patent/KR101897317B1/ko active IP Right Grant
- 2013-01-29 MX MX2014009250A patent/MX354103B/es active IP Right Grant
- 2013-01-29 CA CA2863178A patent/CA2863178C/en active Active
- 2013-01-29 US US14/375,385 patent/US9198977B2/en active Active
- 2013-01-29 TR TR2019/00778T patent/TR201900778T4/tr unknown
- 2013-01-29 CN CN201380017781.9A patent/CN104302315B/zh active Active
- 2013-01-29 JP JP2014555364A patent/JP6042455B2/ja active Active
- 2013-01-29 SG SG11201404447WA patent/SG11201404447WA/en unknown
- 2013-01-29 PT PT13743463T patent/PT2809349T/pt unknown
- 2013-01-29 BR BR112014018815-7A patent/BR112014018815B1/pt active IP Right Grant
- 2013-01-29 EP EP13743463.5A patent/EP2809349B1/en active Active
- 2013-01-29 WO PCT/IB2013/050739 patent/WO2013114268A1/en active Application Filing
- 2013-01-29 ES ES13743463T patent/ES2707294T3/es active Active
- 2013-01-29 DK DK13743463.5T patent/DK2809349T3/da active
- 2013-01-29 RU RU2014134288A patent/RU2634405C2/ru active
- 2013-01-29 HU HUE13743463A patent/HUE040914T4/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6042455B2 (ja) | 2016-12-14 |
| KR20140123553A (ko) | 2014-10-22 |
| BR112014018815B1 (pt) | 2022-07-12 |
| BR112014018815A8 (pt) | 2017-07-11 |
| CA2863178A1 (en) | 2013-08-08 |
| SG11201404447WA (en) | 2014-08-28 |
| MX354103B (es) | 2018-02-13 |
| DK2809349T3 (da) | 2019-02-18 |
| EP2809349B1 (en) | 2018-12-19 |
| KR101897317B1 (ko) | 2018-09-11 |
| ES2707294T3 (es) | 2019-04-03 |
| CN104302315B (zh) | 2018-02-06 |
| MX2014009250A (es) | 2015-03-19 |
| SI2809349T1 (sl) | 2019-03-29 |
| EP2809349A4 (en) | 2015-08-26 |
| EP2809349A1 (en) | 2014-12-10 |
| RU2014134288A (ru) | 2016-03-20 |
| WO2013114268A1 (en) | 2013-08-08 |
| JP2015509111A (ja) | 2015-03-26 |
| CN104302315A (zh) | 2015-01-21 |
| BR112014018815A2 (ru) | 2017-06-20 |
| CA2863178C (en) | 2021-04-06 |
| PT2809349T (pt) | 2019-02-01 |
| HUE040914T4 (hu) | 2019-05-28 |
| US20140377302A1 (en) | 2014-12-25 |
| RU2634405C2 (ru) | 2017-10-26 |
| US9198977B2 (en) | 2015-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201900778T4 (tr) | İmmünojenik bileşim. | |
| PH12021551159A1 (en) | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions | |
| PH12018501517B1 (en) | Neisseria meningitidis compositions and methods thereof | |
| MY148110A (en) | Immunogenic composition | |
| BR112012019757B8 (pt) | Composição imunogênica, e, uso de uma mistura de conjugado de polissacarídeo-proteína multivalente | |
| JP2014218516A5 (ru) | ||
| CL2016000566A1 (es) | Método para para preparar una composición inmunogénica multivalente que comprende 13 conjugados de un serotipo diferente de streptococcus pneumoniae, donde cada uno de los conjugados contiene un polisacárido capsular diferente conjugado a la proteína portadora crm197. div. sol. madre n° 200600802 e hija cl 201702206. | |
| TR201907313T4 (tr) | İki PEG zinciri içeren PEG türevleri. | |
| AR060187A1 (es) | Composicion inmunogenica | |
| BR112020004509A8 (pt) | Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado | |
| BR112019001995A2 (pt) | composição de conjugado de polissacarídeo pneumocócico multivalente ? proteína | |
| RU2009130447A (ru) | Модифицированные сахариды | |
| BRPI0611872B8 (pt) | reagente polimérico, conjugado, método para preparação de um conjugado e composição farmacêutica | |
| MX2020002558A (es) | Procesos para la formulacion de polisacaridos neumococicos para la conjugacion a una proteina transportadora. | |
| RU2007102016A (ru) | Пространственный анализ конъюгатов сахаридов с помощью gpc и sec-mals | |
| IN2014DN09791A (ru) | ||
| BRPI0206672B8 (pt) | composição imunológica, vacina conjugada tetravalente e vacina meningocócica multivalente | |
| BR112013012626A2 (pt) | formulação, composição imunogênica, e, seringa pré-carregada | |
| JP2015518845A5 (ru) | ||
| RU2014151567A (ru) | Конъюгат менингококка серогруппы х | |
| JP2015509111A5 (ru) | ||
| MX2021014710A (es) | Un conjugado inmunogenico de polisacarido de neumococo del serotipo 35b- proteina y proceso de conjugacion para preparar el mismo. | |
| BRPI0516770A (pt) | vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente | |
| BRPI0411875A (pt) | método de imunização contra os sorogrupos a e c de neisseria meningitidis | |
| BRPI0515125A (pt) | conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina |